CRYOMAREX RISPENS
CRYOMAREX RISPENS
Not authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Product identification
Medicine name:
CRYOMAREX RISPENS
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
-
Chicken (one day-old chick)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live3.00/log10 plaque forming unit(s)1.00unit(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1636413 0/1989
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 5/07/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 5/07/2022